Addition of tucatinib to trastuzumab emtansine (T-DM1) in patients with previously treated HER2+ locally advanced/metastatic breast cancer (LA/MBC): updated efficacy analysis from the HER2CLIMB-02 trial
Web preview is not available
Try directly downloading the file.